Gout and secondary amyloid

Clinical Rheumatology

Volumn 18, Issue 1, 1999, Pages 54-55

  Guma M ^a   Bayes B ^a   Bonet, J ^a   Olive A ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Amyloid; Gout

Indexed keywords

ALLOPURINOL; AMYLOID PROTEIN; COLCHICINE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AMYLOIDOSIS; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; GOUT; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; POLYARTHRITIS; PRIORITY JOURNAL; RECTUM BIOPSY;

ALLOPURINOL; AMYLOID; AMYLOIDOSIS; COLCHICINE; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; GOUT; GOUT SUPPRESSANTS; HUMANS; KIDNEY FAILURE; MALE; MIDDLE AGED; RECURRENCE; RENAL DIALYSIS;

EID: 0032966481     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100670050053     Document Type: Article

References (6)

1. Lens XM, Roselló R, Montoliu J, Solé M. Sornell A, Rotés J, et al. Amyloidosis secondary to gout. J Rheumatol 1985;12:1024-6.
2. Rubinow A, Sonnemblinck M. Amyloidosis secondary to polyarticular gout. Arthritis Rheum 1991;24:1425-7.
3. Jacobelli S, Vial S, Rosenberg H. Amyloidosis secondary to gout. Identification with a monoclonal antibody to amyloid protein A. Clin Rheumatol 1988;7:534-7.
4. Sheinberg MA, Benson MO. SAA amyloid protein levels in amyloid-prone chronic inflammatory disorders. Lack of association with amyloid disease. J Rheumatol 1980:5:724-6.
5. Zemer D, Livneh A, Danon YL, Pras M, Sohor E. Long-term colchicine treatment in children with familial Mediterranean fever. Arthritis Rheum 1991;34:973-7.
6. Shirahama T, Cohen AS. Blockage of amyloid induction by colchicine in a animal model. J Exp Med 1974;140:1102-7.